13,16,19-Docosatrienoicacid, methyl ester, (13Z,16Z,19Z)-

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 13,16,19-Docosatrienoicacid, methyl ester, (13Z,16Z,19Z)-
• 英文别名: methyl (13Z,16E,19E)-docosa-13,16,19-trienoate
• 化学式: C₂₃H₄₀O₂
• 分子量: 348.6
• InChiKey: RXNIYBHTXVTSAK-GVNKBMKVSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.4
• 重原子数：
  25
• 可旋转键数：
  18
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.7
• 拓扑面积：
  26.3
• 氢给体数：
  0
• 氢受体数：
  2

文献信息

• METHOD FOR ALLEVIATING FEAR MEMORY
  申请人：Sekiguchi Masayuki

  公开号：US20140121276A1

  公开（公告）日：2014-05-01

  The present invention provides new methods of intervention for anxiety associated disorders, in particular, trauma-derived disorders such as PTSD, and therapeutic or prophylactic agents for anxiety associated disorders that can be used as foods, beverages, and dietary supplements, for example, and which contain as an active ingredient n-3 polyunsaturated fatty acids contained in krill oil or fish oil, for example. The present invention further provides methods for alleviating fear memory or methods for preventing its formation by adjusting the proportion of n-3 polyunsaturated fatty acids to n-6 polyunsaturated fatty acids as ingested.
• US9107891B2
  申请人：——

  公开号：US9107891B2

  公开（公告）日：2015-08-18